Consumer health

Novartis, Boehringer debut DTC programs with reduced drug prices

Novartis and Boehringer Ingelheim outlined plans on Monday to launch direct-to-patient platforms that will reduce the prices of popular medicines in the U.S.

Andrea Park Sep 29, 2025 12:06pm

AstraZeneca debuts DTC service with discounted Farxiga, Airsupra

Sep 26, 2025 10:51am

BMS puts discounted Sotyktu at the center of next DTC platform

Sep 25, 2025 11:01am

BMS sells majority stake in historic US-China pharmaceutical JV

Sep 15, 2025 10:09am

Graphic of two hands shaking under a red and purple light

PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT

Sep 11, 2025 10:25am

Lilly links up with JD Health for DTC drug sales in China

Aug 29, 2025 10:20am

More News

AstraZeneca begins DTC home delivery of FluMist vaccine

Aug 15, 2025 10:05am

BlinkRx offers launch support to new pharma DTC programs

Aug 12, 2025 11:00am

Kenvue's strategic review stirs up CEO departure

Jul 15, 2025 11:22am

Perrigo locks in €327M sale of skincare and cosmetics business

Jul 15, 2025 10:31am

See more stories